Your browser doesn't support javascript.
loading
A Unique Case of Goodpasture's Syndrome-Induced Cardiorenal Syndrome.
Chinniah, Chidambaram; Pyronneau, Alexander; Stepman, Gauthier; Ali, Rias.
Affiliation
  • Chinniah C; Cardiology, HCA Healthcare/University of South Florida Morsani College of Medicine, Graduate Medical Education at HCA Florida Trinity Hospital, Trinity, USA.
  • Pyronneau A; Internal Medicine, HCA Healthcare/University of South Florida Morsani College of Medicine, Graduate Medical Education at HCA Florida Trinity Hospital, Trinity, USA.
  • Stepman G; Cardiology, HCA Healthcare/University of South Florida Morsani College of Medicine, Graduate Medical Education at HCA Florida Trinity Hospital, Trinity, USA.
  • Ali R; Cardiology, HCA Healthcare/University of South Florida Morsani College of Medicine, Graduate Medical Education at HCA Florida Trinity Hospital, Trinity, USA.
Cureus ; 16(7): e64269, 2024 Jul.
Article in En | MEDLINE | ID: mdl-38988901
ABSTRACT
Goodpasture's syndrome (GPS) is a rare small vessel vasculitis characterized by circulating antibodies directed against the glomerular and alveolar basement membrane leading to renal and pulmonary manifestations. Here, we discuss a unique case of a 30-year-old Caucasian male smoker initially presenting with hemoptysis and anemia who was found to have biopsy-proven GPS with elevated anti-glomerular basement membrane (anti-GBM) antibodies. Unfortunately, the patient failed four months of standard treatment for GPS leading to end-stage renal disease (ESRD), while uniquely developing cardiorenal syndrome (CRS) with non-ischemic cardiomyopathy resulting in systolic and diastolic heart failure (HF). Despite aggressive medical management and hemodialysis, the patient's cardiac function continued to decline and the decision was made to insert an automatic implantable cardioverter defibrillator (AICD). To our knowledge, this is the first reported case of an anti-GBM-positive GPS patient who developed dilated cardiomyopathy. The importance of this report is to illustrate the rarity of developing CRS with non-ischemic cardiomyopathy and congestive heart failure from GPS and highlight the difficulty of determining management changes beyond guideline-directed medical therapy (GDMT) in GPS to slow the progression of worsening cardiac function.
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Cureus Year: 2024 Document type: Article Affiliation country: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Cureus Year: 2024 Document type: Article Affiliation country: United States